GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (TSX:SVA) » Definitions » Research & Development

Sernova (TSX:SVA) Research & Development : C$29.65 Mil (TTM As of Jul. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Sernova Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sernova's Research & Development for the three months ended in Jul. 2024 was C$5.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jul. 2024 was C$29.65 Mil.


Sernova Research & Development Historical Data

The historical data trend for Sernova's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Research & Development Chart

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 2.76 4.64 16.90 32.04

Sernova Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.43 9.68 7.24 7.71 5.02

Sernova Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jul. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$29.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova  (TSX:SVA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Sernova Research & Development Related Terms

Thank you for viewing the detailed overview of Sernova's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.
Executives
Steven Sangha Director
Brett Alexander Whalen Director
Jeffrey Bacha Director

Sernova Headlines

From GuruFocus

SINOVAC to Showcase Products at CPHI Frankfurt

By Business Wire Business Wire 10-28-2022